title: Which is the outcome of the post-thrombotic syndrome?
authors.forename: P
authors.initials: P
authors.lastname: Prandoni
authors.forename: A W
authors.initials: AW
authors.lastname: Lensing
authors.forename: M H
authors.initials: MH
authors.lastname: Prins
authors.forename: P
authors.initials: P
authors.lastname: Bagatella
authors.forename: A
authors.initials: A
authors.lastname: Scudeller
authors.forename: A
authors.initials: A
authors.lastname: Girolami
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011186:Postphlebitic Syndrome / Q000188:drug therapy; D011379:Prognosis; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin